Библиография

1. Wu, J., Fujioka, M., Sugimoto, K., Mu, G. and Ishimi, Y. 2004. Assessment of effectiveness of oral administration of collagen peptide on bone metabolism in growing and mature rats. Journal of bone and mineral metabolism, 22:47-553.

2. Asghar, A and Henrickson, R.L. 1982. Chemical, biochemical, functional characteristics of collagen in food system. Advances in food research, 28:231-372.

3. Oesser, S., Adam, M., Babel, W. and Seifert, J. 1999. Oral administration of 14C labeled gelatinhydrolysate leads to an accumulation of radioactivity in cartilage of mice (C57/BL). Journal of nutrition, 129:1891-1895.

4. Iwai, K., Hasegawa, T., Taguchi, Y., Morimatsu, F., Sato, K., Nakamura, Y., Higashi, A., Kido, Y., Nakabo, Y. and Ohtsuki, K. 2005. Identification of foodderived collagen peptides in human blood after oral ingestion of gelatin hydrolysates. Journal of agricultural and food chemistry, 53: 6531-6536.

5. Postlethwaite, A.E., Seyer, J.M., and Kang, A.H. 1978. Chemotactic attraction of human fibroblasts to type I, II, and II collagens and collagen-derived peptides. Proceedings of the National Academy of Sciences of the United States of America. 75(2): 871-875.

6. Minaguchi, J., Koyama, Y-I., Meguri, N., Hosaka, Y., Ueda, H., Kusubata, M., Hirota, A., Irie, S., Mafune, N. and Takehana, K. 2005. Effects of ingestion of collagen peptide on collagen fibrils and glycosaminoglycans in Achilles tendon. Journal of nutritional science and vitaminology 51:169-174.

7. Matsuda, N., Koyama, Y-I., Hosaka, Y., Ueda, H., Watanabe, T., Araya, S., Irie, S. and Takehana, K. 2006. Effects of ingestion of collagen peptide on collagen fibrils and glycosaminoglycans in the dermis. Journal of nutritional science and vitaminology. 52: 211-215.

8. Matsumoto, H., Ohara, H., Ito, K., Nakamura, Y. and Takahashi, S. 2006. Clinical effects of fish type I collagen hydrolysate on skin properties. ITE Letters on batteries,

9. Porter JM et al. International Consesus Committee on chronic venous disease. J Vasc Surg 1995; 21:635-645.

10. Gunderso J, Hauge M. Hereditary factors in venous insufficiency. Angiology 1969; 20(6):346-355.

11. Cornu-thenard A et al. Importance of the familial factors in varicose disease. Clinica study in 134 families. J Derm Surg Onc 1994; 20:318-326.

12. Scott HJ et al. Histological study of white blood cells their association with lipodermatosclerosis and venous ulceration. Br J Surg 1991; 78:210-211.

13. Thomas P, Nash JB.White cell accumulation in depend legs of patients with venous hypertension: A possible mechanism for trophic changes in the skin. Br Med J1988; 296:1693-1695.

14. Perschen M et al. Increased expression of of platelet-derived growth factor receptor alpha and beta and vascular endothelial growth factor in the skin in patients with chronic venous insufficiency. Arh Dermatol Res 1998; 290:291-297.

15. Navarro L, Min R, Bone C. Endovenous laser: A new minimally invasive method of treatment of varicous veis - preliminary observation using an 810nm diode laser. Dermatol Surg 2001; 27:117-122.

16. Garner JP et al. The latera accessory saphenous vein – A common cause of recuurent varicous veins. Ann R Coll Surg Engl 2003; 85:389-392.

17. Jantet G. RELIEF study: first consolidated European data. Angiology. 2000;51:31-37

18. Захариев Т. и съавт. Епидемиологично проучване на хроничната ванозна болест в България Phlebolymphology 2006

19. Ramelet A.q Kern P., Varicose veins and teleangiectasias

20. Bradbury A, Evans C, Allan P, Lee A, Ruckley CV, Fowkers FGR. What are the symptoms of varicose veins? Edinburgh vein study cross sectional population survey. Br Med J 1999;319:353–356.

21. Moore HD. Deep venous valves in the etiology of varicose veins. Lancet 1951;2:7–10.

22. Cooper DG, Hillman-Cooper CS, Barker SG, Hollingsworth SJ. Primaryvaricose veins: the sapheno-femoral junction, distribution of varicosities and pattern of incompetence. Eur J Vasc Endovasc Surg 2003;25:53–90.

23. Wong JKF, Duncan JL, Nichols DM. Whole-leg duplex mapping for varicose veins: observations on patterns of reflux in recurrent and primary legs, with clinical correlation. Eur J Vasc Endovasc Surg 2003;25:267–275.

24. Golledge J, Quigley FG. Pathogenesis of varicose veins. Eur J Vasc Endovasc Surg 2003;25:319–324.

25. Rose SS, Ahmed A. Some thoughts on the etiology of varicose veins. J Cardiovasc Surg 1986;27:534–543.

26. Gandhi RH, Irizarry E, Nackman GB, Halpern VJ, Mulcare RJ, Tilson MD. Analysis of the connective tissue matrix and proteolytic activity of primary varicose veins. J Vasc Surg 1993;18:814–820.

27. Psaila JV, Melhuish J. Viscoelastic properties and collagen content of the long saphenous vein in normal and varicose veins. Br J Surg 1989;76:37–40.

28. Sansilvestri-Morel P, Rupin A, Badier-Commander C. Imbalance in the synthesis of collagen type I and collagen type III in smooth muscle cells derived from human varicose veins. J Vasc Res 2001;38:560–568.

29. Travers JP, Brookes CE, Evans J, Baker DM, Kent C, Makin GS, MayhewTM. Assessment of wall structure and composition of varicose veinswith reference to collagen, elastin and smooth muscle content. Eur JVasc Endovasc Surg 1996;11:230–237.

30. Kockx MM, Knaapen MW, Bortier HE, Cromheeke KM, Boutherin-FalsonO, Finet M. Vascular remodeling in varicose veins. Angiology 1998;49:871–877.

31. Wali MA, Eid RA. Smooth muscle changes in varicose veins: an ultrastructural study. J Smooth Muscle Res 2001;37:123–135.

32. Dovell T. Morphological examination and quantification of smooth muscle content of varicose vein walls. B Med Sci Thesis, Department of Human Morphology, University of Nottingham, 1992.

33. Krasinski Z, Kotwicka M, Oszkinis G, Dzieciuchowicz L, Borkiewicz P,Wasko R, Gabriel M. Investigations on the pathogenesis of primary varicose veins. Wiad Lek 1997;50:275–280.

34. Porter JM, Moneta GL. International consensus committee on chronic venous disease. Reporting standards in venous disease: an update. J Vasc Surg 1995;2:635–645.

35. Wali MA, Eid RA. Intimal changes in varicose veins: an ultrastructural study. J Smooth Muscle Res 2002;38:63–74.

36. Coleridge-Smith PD. The microcirculation in venous hypertension. Vasc Med 1997;2:203–213.

37. Wali MA, Dewan M, Eid RA. Histopathological changes in the wall of varicose veins. Int Angiol 2003;22:188–193.

38. Ducasse E, Giannakakis K, Chevalier J, Dasnoy D, Puppinck P, SpezialeF, Fiorani P, Faraggiana T. Dysregulated apoptosis in primary varicose veins. Eur J Vasc Endovasc Surg 2005;29:316–323.

39. Lee TA, Mantle D, Lambert D. A comparison of smooth musclederived proteolytic enzymes in normal and varicose veins. Phlebology 1992a;92:49–51.

40. Lee TA, Mantle D, Lambert D. Analysis of the smooth muscle content in normal and varicose vein wall via analytical electrophoresis. Phlebology 1992b;92:56–58.

41. Clarke GH, Vardakas SN, Hobbs JT, Nicolaides AN. Venous wall functionin the pathogenesis of varicose veins. Surgery 1992;111:402–408.

42. Brunner F, Hoffman C, Schuller-Petrovic S. Responsiveness of human varicose saphenous vein to vasoactive agents. Br J Clin Pharmacol 2001;51:219–224.

43. Stahl A, Muellar BM. The urokinase-type plasminogen activator receptor,a GPI-linked protein, is localized in caveolae. J Cell Biol 1995;129:335–343. 44. Venturi M, Bonavina L, Annoni F, Colombo L, Butera C, Peracchia A, Mussini E. Biochemical assay of collagen and elastin in the normal and varicose vein wall. J Surg Res 1996;60:245–248.